rmhTNF-α combined with cisplatin inhibits proliferation of A549 cell line in vitro / 中国医学科学杂志(英文版)
Chinese Medical Sciences Journal
;
(4): 185-187, 2014.
Artigo
em Inglês
| WPRIM
| ID: wpr-242873
ABSTRACT
<p><b>OBJECTIVE</b>To explore the inhibitory effect of recombinant mutant human tumor necrosis factor-Α (rmhTNF-Α) in combination with cisplatin on human lung adenocarcinoma cell line A549.</p><p><b>METHODS</b>Human lung adenocarcinoma cell line A549 was treated with varying concentrations of rmhTNF-Α (0.38, 0.75, 1.50, 6.00 and 12.00 IU/ml) or cisplatin (3.91, 7.81, 15.63, 31.25 and 62.50 Μg/ml) for 24 hours. Viable cell number was analyzed by using crystal violet staining. The inhibitory rates of A549 cells growth by the two drugs were calculated. For analyzing whether there was a synergistic effect of rmhTNF-Α with cisplatin, A549 cells were treated with 0.75 IU/ml rmhTNF-Α and increased concentrations of cisplatin.</p><p><b>RESULTS</b>rmhTNF-Α or cisplatin inhibited the growth of A549 cell lines in a dose-dependent manner. The inhibitory effect of rmhTNF-Α combined with cisplatin was significantly greater than cisplatin alone at the same concentration (all P<0.01).</p><p><b>CONCLUSION</b>rmhTNF-Α combined with cisplatin might have synergistic inhibitory effect on human lung adenocarcinoma cell line A549.</p>
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Patologia
/
Farmacologia
/
Proteínas Recombinantes
/
Adenocarcinoma
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Fator de Necrose Tumoral alfa
/
Cisplatino
/
Linhagem Celular Tumoral
/
Usos Terapêuticos
/
Proliferação de Células
Limite:
Humanos
Idioma:
Inglês
Revista:
Chinese Medical Sciences Journal
Ano de publicação:
2014
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS